HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives
The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month.
You may also be interested in...
UK consumers “may be falling back into pre-pandemic behaviours and there is a time-limited opportunity to embed the changes people had embraced during the pandemic,” argues PAGB CEO Michelle Riddalls as the association publishes its latest self-care survey.
A study backed by HRA Pharma found that 65% of women in Italy, 55% in Spain and 49% in Germany feel positive about accessing a progestin-only oral contraceptive pill without a prescription. HRA told HBW Insight that the research "confirms it is now time for better access to more effective contraception:"
Perrigo subsidiary HRA Pharma's Compeed foot-care brand is sponsoring the UK's Wendy Searle in her attempt to break the world record for fastest woman to ski solo and unassisted from the Antarctic coast to the South Pole this winter.